Downloads
-
Guidelines For Defining A Control Strategy Framework For Accelerated mAb Programs
11/6/2025
This article assembles an industrywide “platform” knowledge base on the impact of parameters across unit operations in a standard mAb process.
-
Your New Control Center For Cell Therapy Process Development
11/6/2025
Achieve twice the cell yield in early-stage cell therapy development using a proven, scale-down bioreactor model. Parallel power and closed-system operation accelerate results with lower risk.
-
A Multi-Omics Approach For Characterizing Clinical-Scale iPSC Batches
11/6/2025
The transition from 2D to 3D cell culture requires a combination of advanced analytical techniques, but aligning new methods with established principles can be challenging.
-
Achieve Pharma 4.0 With Next Generation Software-Defined Manufacturing
11/5/2025
Explore how software-defined manufacturing is helping companies overcome legacy system challenges, improve OEE by up to 25%, and accelerate batch release cycles while maintaining compliance.
-
Global Implications Of Zero Tariffs On Indian Pharma Exports To China
11/5/2025
Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
11/5/2025
Among other reasons, academic centers have access to sophisticated technology. In contrast, manufacturing suites must use established, validated methods.
-
Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment
11/4/2025
Explore filtration strategies that improve viral vector yield and quality, with insights on AAV and lentivirus workflows, plus practical guidance for implementing PUPSIT in line with requirements.
-
Use Cation Exchange Chromatography For High Yields In Vaccine Production
11/4/2025
Learn how to achieve high yields in vaccine production by using Cation Exchange Chromatography for purifying SARS-CoV-2 spike proteins. This method provides high purity and minimizes protein aggregates.
-
Leveraging 3 Distinct Resins To Provide Effective Impurity Removal For mAbs And Novel Antibody Derivatives
11/3/2025
Due to the complexity of bispecifics, Fc-fusion proteins, and Fab fragments, their manufacturing poses added purification challenges and requires a robust toolkit of purification techniques.
-
Expansion Of Human Bone Marrow-Derived MSCs
11/3/2025
Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.